G-CON PODs Selected by Matica Biotechnology for GMP Viral Vector...

PODs will support the CDMO’s clinical and commercial production of cell and gene therapies.(PRWeb March 23, 2021)Read the full story at https://www.prweb.com/releases/g_con_pods_selected_by_matica_biotechnology_for_gmp_viral_vector_facility_in_college_station_tx/prweb17812189.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news